Search
for
Sort by
Research 361–390 of 820
- Incidence of alopecia in brain tumour patients treated with pencil scanning proton therapy and validation of existing NTCP models
- Loss of Ten1 in mice induces telomere shortening and models human dyskeratosis congenita
- Supplementary material for: Microinjury-Induced Tumor Necrosis Factor-α Surge Stimulates Hair Regeneration in Mice
- Long-term hair loss associated with brentuximab vedotin–containing chemotherapy and its psychosocial impact: A retrospective observational study conducted at the Royal Marsden Hospital.
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Scalp cooling therapy for chemotherapy-induced hair loss in Asian patients with breast or gynecological cancers – a tertiary institution experience
- 766 H3K9me3 methyltransferase SETDB1 controls retrotransposon silencing, DNA methylation, constitutive heterochromatin maintenance and 3D-chromatin structure in epidermal keratinocytes
- Effect of a medicinal and edible decoction YH0618 on chemotherapy-induced dermatologic toxicity: a randomized controlled trial
- Safety profile of CAP7.1 obtained during Phase I Trial in adult patients with refractory malignancies
- Abstract P5-21-05: ERALOP study: Post adjuvant FEC - docetaxel chemotherapy for early breast cancer: Hair regrowth in the real life
- Electronic Brachytherapy for the Treatment of Nonmelanoma Skin Cancer: Results at 3 Years
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management
- Erlotinib-Associated Alopecia in a Lung Cancer Patient
- The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial
- Off-label uses of retinoids in dermatology
- Pitfalls of PCR-Based Strategy for Genotyping <i>Cre-Loxp</i> Mice
- Gender-specific side effects of chemotherapy in pancreatic cancer patients
- CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients.
- The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial
- Bexarotene gel: A new topical therapy for alopecia areata
- Hydrogel-Based Strategies for the Prevention and Treatment of Radiation-Induced Skin Injury: Progress and Mechanistic Insights
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- 567 Acute generalized exanthematous pustulosis (AGEP) induced by plaquenil
- Whole brain radiotherapy with partial hair-sparing technique-a feasibility study
- P13.14 * PROPHYLACTIC USE OF SHIUNKO IN THE PREVENTION OF RADIATION-INDUCED SCALP DERMATITIS: A PRELIMINARY REPORT
- Scalp cooling versus standard cold-cap in preventing chemotherapy-induced alopecia in patients with localized breast cancer: ICELAND protocol, a randomized controlled trial and economic evaluation
- Pharmacogenomic variation and chemotherapy-related toxicity profiles in pediatric patients with cancer in Tanzania: a cross-sectional study
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Cutaneous epitheliotropic T‐cell lymphoma in a sugar glider (<i>Petaurus breviceps</i>)